Micro Current Neurofeedback (MCN) is a technology that helps the brain using transelectrical energy reorganize and balance itself. MCN helps improve the symptoms of PTSD, TBI, anxiety, depression and ADD/ADHD

Conditions helped by IASIS Micro Current Neurofeedback (MCN) overlap those of traditional neurofeedback. However, it is common for a patient to plateau with traditional neurofeedback and then experience additional progress utilizing IASIS MCN. And it is much more efficient.

Our experience with MCN microcurrent neurofeedback is significant: over 85% of clients begin to observe a noticeable positive response in 1-3 session however for lasting, sustained results we recommend 15- 20 sessions.

Application of Micro Current Neurofeedback While seated, five lightweight EEG electrodes will be placed at different areas on your head and neck. The areas will first be cleaned off and then a conductive paste will be applied to hold the electrodes in place. The position of the electrodes may vary through the treatment and in subsequent treatments. The device is then turned on and MCN begins. You will feel as if nothing is happening as MCN is very safe and well- tolerated. Dr. Hawkins will determine, based on your history and current symptoms, which protocol (to include EEG electrode placement) is best for you!

ADD ADHD Addiction Anxiety Autism Spectrum Disorder Cancer Chronic Fatigue Syndrome Dementia Depression Eating Disorders Epilepsy Fibromyalgia Headache Insomnia Lyme Disease Memory Disorders Migraine Parkinson's Disease Post Traumatic Stress Disorder Raynaud's Disease Stroke Traumatic Brain Injury

A Pilot Treatment Study for Mild Traumatic Brain Injury: Neuroimaging Changes Detected by Meg After Low-Intensity Pulse-Based Transcranial Electrical Stimulation Brain Injury & Micro Current Neurofeedback Background: Mild traumatic brain injury (mTBI) is a leading cause of sustained impairments in military service members, Veterans, and civilians. However, few treatments are available for mTBI, partially because the mechanism of persistent mTBI deficits is not fully understood. Methods: We used magnetoencephalography (MEG) to investigate neuronal changes in individuals with mTBI following a passive neurofeedback-based treatment programme called IASIS MCN. This programme involved applying low-intensity pulses using transcranial electrical stimulation (LIP-tES) with electroencephalography monitoring. Study participants included six individuals with mTBI and persistent postconcussive symptoms (PCS). MEG exams were performed at baseline and follow-up to evaluate the effect of IASIS MCN on brain functioning. Results: At the baseline MEG exam, all participants had abnormal slow-waves. In the follow-up MEG exam, the participants showed significantly reduced abnormal slow-waves with an average reduction of 53.6 ± 24.6% in slow-wave total score. The participants also showed significant reduction of PCS scores after IASIS MCN treatment, with an average reduction of 52.76 ± 26.4% in PCS total score. Conclusions: The present study demonstrates, for the first time, the neuroimaging-based documentation of the effect of LIP-tES treatment on brain functioning in mTBI. The mechanisms of LIP-tES treatment are discussed, with an emphasis on LIP-tES’s potentiation of the mTBI healing process.

Unfortunately , most medical plans do not cover MCN when the diagnosis is a psychiatric condition. Some plans do cover MCN for medical diagnosis is primary (i.e urinary incontinence) At TMS DCM we only use MCN treating symptoms associated with psychiatric condition.